Mr. David A. Pierce is Senior Vice President and President Endoscopy of Boston Scientific Corporationrationration, since January 2011. Prior to his current role, Mr. Pierce served as Vice President, Marketing for the Company Endoscopy Division from April 2006 until January 2011. From December 2004 until March 2006, Mr. Pierce was the Group Marketing Director in the Company Endoscopy Division. He joined Company in 1991 as a Territory Manager before assuming managementlevel positions of increasing responsibility. Before joining the Company, Mr. Pierce worked as a Senior Sales Representative for Airborne Express and served as a Captain in the United States Army. He earned a B.S. in Business Administration from Norwich University and an M.B.A. from Boston University.
Senior Vice President and President - Endoscopy
Age: 48 President Since 2011 MBA
The company has Return on Asset of 3.1 % which means that on every $100 spent on asset it made $3.1 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of (50.67) % meaning that it generated no profit with money invested by stockholders.
The company has 4.25 B in debt with debt to equity (D/E) ratio of 0.65 which is OK given its current industry classification. Boston Scientific Corporation has Current Ratio of 1.86 which is typical for the industry and considered as normal.
Entity SummaryBoston Scientific Corporationration develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific Corporation [BSX] is traded on New York Stock Exchange in USA. It is located in Natick, MA and employs 24,000 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| BSX NYSE
Boston Scientific Corporation
Boston Scientific Corporation has less than 43.4 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Boston price boundaries
Promote Boston and David Pierce